Initial survival outcomes for the AGITG GAP study a phase II study of perioperative nab-paclitaxel and gemcitabine for resectable pancreatic ductal adenocarcinoma (PDAC)

Andrew P. Barbour, Nicholas O'Rourke, Howard Chan, YuJo Chua, James Kench, Rodney J. Hicks, Jaswinder S Samra, N. Pavlakis, Koroush Haghighi, Sonia Yip, Mark Donoghoe

    Research output: Contribution to journalLiterature review

    Original languageEnglish
    Pages (from-to)Abstract Number: 4105
    JournalJournal of Clinical Oncology
    Issue numberSupplement 5
    Publication statusPublished - 2016

    Cite this